Arunkanth Krishnakumar serves as the Co-Founder and Director of ZEUS HYGIA LIFE SCIENCES PRIVATE LIMITED, focusing on building healthier solutions in the life sciences sector since July 2018.
Prior to ZEUS HYGIA, Arunkanth held the position of General Manager for Product Development at Celltrion Pharm Inc from March 2012 to May 2017, overseeing key product innovations and developments.
Experience as a Manager/Scientist II in Formulation R&D at Aurobindo Pharma from September 2009 to March 2012 contributed to significant advancements in drug formulation techniques.
Engaged in research initiatives as an Associate Research Scientist at Zydus Cadila from January 2007 to September 2009, contributing to various scientific projects and studies.
Worked at Dr. Reddy's Laboratories from August 2005 to December 2006 as a Junior Manager in NDDS and Generic Formulation R&D, playing a crucial role in developing new drug delivery systems.
Initiated professional career as a Research Associate in Formulation R&D at Cipla from June 2003 to July 2005, gaining foundational experience in pharmaceutical research.
Throughout this career trajectory, Arunkanth has encountered challenges typical in the pharmaceutical industry, including regulatory hurdles and the need for innovative solutions in drug development.
Milestones achieved include leading teams to successfully launch health-focused projects and products aimed at improving patient outcomes and public health.
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Zeus Hygia Life Sciences Private Limited corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Arunkanth Krishnakumar , Phd ,Mba's net worth? Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them? Through Zeus Hygia Life Sciences Private Limited's official communication channels.
Is this an official profile? No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible
information and independent research. While accuracy is prioritized, content may not always reflect the
latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured
has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication
channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)